ABCA4-related Cone-Rod Dystrophy
Genetics
Usually autosomal recessive and caused by biallelic pathogenic variants in ABCA4. Residual transporter activity and the combination of severe and hypomorphic alleles strongly influence age at onset and progression.
Molecular Mechanism
ABCA4 transports N-retinylidene-phosphatidylethanolamine across photoreceptor disc membranes. Deficiency promotes bisretinoid formation and A2E-rich lipofuscin accumulation in retinal pigment epithelium, leading to RPE toxicity and secondary photoreceptor loss.
Therapy
No ABCA4-specific therapy is approved. Management includes low-vision support and avoidance of unnecessary high-dose vitamin A supplementation. Large-gene delivery, gene editing, visual-cycle modulation and cell-based approaches are under development.
CCP Activity
CCP designs and prepares development of clinically relevant mouse models.
Mouse Models Mouse Models & Gene Cards
| Mouse Models | Gene Cards |
|---|---|
| TBD | TBD |